Dominari (DOMH) 10-Q 10 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 08, 2023
Document Information Line Items
Entity Registrant Name	Dominari Holdings Inc.
Trading Symbol	DOMH
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		4,592,578
Amendment Flag	false
Entity Central Index Key	0000012239
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-05576
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-0849320
Entity Address, Address Line One	725 5th Avenue
Entity Address, Address Line Two	22nd Floor,
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	(703)
Local Phone Number	992-9325
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock, $0.0001 par value
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 9,533	$ 33,174
Marketable securities	24,394	7,130
Clearing broker deposits	3,550
Prepaid expenses and other current assets	745	564
Prepaid acquisition cost		301
Short-term investments at fair value	13	13
Notes receivable, at fair value - current portion	6,536	7,474
Investment in Fieldpoint Securities		2,000
Total current assets	44,771	50,656
Property and equipment, net	353
Notes receivable, at fair value - non-current portion	1,850	1,100
Investments	23,103	23,103
Right-of-use assets	3,619	919
Security deposit	458	458
Total assets	74,154	76,236
Current liabilities
Accounts payable and accrued expenses	641	447
Accrued salaries and benefits	732	1,260
Accrued Commissions	25
Lease liability - current	198	82
Other Current liability	124
Total current liabilities	1,720	1,789
Lease liability	3,363	680
Total liabilities	5,083	2,469
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 100,000,000 shares authorized; 4,815,597 and 5,485,096 shares issued at March 31, 2023 and December 31, 2022, respectively; 4,755,449 and 5,017,079 shares outstanding at March 31, 2023 and December 31, 2022, respectively
Additional paid-in capital	259,215	262,970
Treasury stock, at cost, 60,148 and 468,017 shares at March 31, 2023 and December 31, 2022, respectively	(501)	(3,322)
Accumulated deficit	(189,643)	(185,881)
Total stockholders’ equity	69,071	73,767
Total liabilities and stockholders’ equity	74,154	76,236
Series D Preferred Stock
Stockholders’ equity
Preferred stock value
Series D-1 Preferred Stock
Stockholders’ equity
Preferred stock value

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized	50,000,000	50,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	4,815,597	5,485,096
Common stock, shares outstanding	4,755,449	5,017,079
Treasury stock, at cost	60,148	468,017
Series D Preferred Stock
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	3,825	3,825
Preferred stock, outstanding	3,825	3,825
Liquidation preference (in Dollars per share)	$ 0.0001	$ 0.0001
Series D-1 Preferred Stock
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	834	834
Preferred stock, outstanding	834	834
Liquidation preference (in Dollars per share)	$ 0.0001	$ 0.0001

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating costs and expenses
General and administrative	$ 3,833	$ 1,787
Research and development	1	2,016
Total operating expenses	3,834	3,803
Loss from operations	(3,834)	(3,803)
Other (expenses) income
Other income		64
Interest income	137	179
Loss on marketable securities	(65)	(497)
Change in fair value of investments		522
Total other (expenses) income	72	268
Net loss	(3,762)	(3,535)
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock		(3,009)
Net Loss Attributable to Common Shareholders	$ (3,762)	$ (6,544)
Net loss per share, basic and diluted
Basic (in Dollars per share)	$ (0.71)	$ (1.25)
Weighted average number of shares outstanding, basic and diluted
Basic (in Shares)	5,305,513	5,252,517

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Diluted	$ (0.71)	$ (1.25)
Diluted	5,305,513	5,252,517

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Redeemable Convertible Preferred Stock Series O	Redeemable Convertible Preferred Stock Series P	Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Total
Balance at Dec. 31, 2021					$ 265,633	$ (264)	$ (163,774)	$ 101,595
Balance (in Shares) at Dec. 31, 2021			4,659	5,275,329		0
Issuance of Series O redeemable convertible preferred stock for cash	$ 11,000
Issuance of Series O redeemable convertible preferred stock for cash (in Shares)	11,000
Issuance of Series P redeemable convertible preferred stock for cash		$ 11,000
Issuance of Series P redeemable convertible preferred stock for cash (in Shares)		11,000
Cost on issuance of Series O and Series P Redeemable Convertible Preferred Stock	$ (1,504)	$ (1,505)
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	1,504	1,505			(3,009)			(3,009)
Cancellation of common stock related to investment in CBM
Cancellation of common stock related to investment in CBM (in Shares)				(22,812)
Net loss							(3,535)	(3,535)
Balance at Mar. 31, 2022	$ 11,000	$ 11,000			262,624	$ (264)	(167,310)	95,051
Balance (in Shares) at Mar. 31, 2022	11,000	11,000	4,659	5,252,517		0
Balance at Dec. 31, 2022					262,970	$ (3,322)	(185,881)	73,767
Balance (in Shares) at Dec. 31, 2022			4,659	5,485,096		468,017
Stock-based compensation					5			5
Stock-based compensation (in Shares)
Cancellation of common stock
Cancellation of common stock (in Shares)				(25,000)
Purchase of treasury stock						$ (939)		(939)
Purchase of treasury stock (in Shares)						236,630
Retirement of treasury stock					(3,760)	$ 3,760
Retirement of treasury stock (in Shares)				(644,499)		(644,499)
Net loss							(3,762)	(3,762)
Balance at Mar. 31, 2023					$ 259,215	$ (501)	$ (189,643)	$ 69,071
Balance (in Shares) at Mar. 31, 2023			4,659	4,815,597		60,148

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (3,762)	$ (3,535)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of right-of-use assets	92
Depreciation	7
Change in fair value of short-term investment		886
Change in fair value of long-term investment		(1,408)
Stock-based compensation	5
Realized loss on marketable securities	56	224
Unrealized loss on marketable securities	130	333
Realized gain on sale of digital currencies		(64)
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(221)	66
Prepaid acquisition cost	301
Accounts payable and accrued expenses	(19)	(172)
Accrued salaries and benefits	(528)	6
Lease liabilities	7
Other current liabilities	3
Notes receivable, at fair value – net interest accrued	(62)	(179)
Deposit		7
Net cash used in operating activities	(3,991)	(3,836)
Cash flows from investing activities
Purchase of marketable securities	(17,519)	(27,096)
Sale of marketable securities	68	24,662
Proceeds from sale of digital currencies		93
Purchase of fixed assets	(361)
Acquisition of FPS, net of cash acquired and receivable owed from FPS	(1,149)
Collection of principal on note receivable	250
Purchase of short-term and long-term investments		(7,737)
Net cash used in investing activities	(18,711)	(10,078)
Cash flows from financing activities
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost		18,991
Purchase of treasury stock	(939)
Net cash (used in) provided by financing activities	(939)	18,991
Net (decrease) increase in cash and cash equivalents and restricted cash	(23,641)	5,077
Cash and cash equivalents, beginning of period	33,174	65,562
Cash and cash equivalents, end of period	9,533	70,639
Non-cash investing and financing activities
Transfer from short-term investment to marketable securities		1,482
Reclassify from convertible note receivable to notes receivable at fair value		$ 2,147
On March 27, 2023, the Company acquired all assets and liabilities of FPS as disclosed in Note 4:
Net assets acquired, net of cash acquired and receivable owed from FPS	3,149
Less - Deposit previously transferred in October 2022 to FPS	(2,000)
Net cash paid	$ 1,149

Organization and Description of

Organization and Description of Business and Recent Developments	3 Months Ended
	Mar. 31, 2023
Organization and Description of Business and Recent Developments [Abstract]
Organization and Description of Business and Recent Developments	Note 1. Organization and Description of Business and Recent Developments Organization and Description of Business Dominari Holdings Inc. (the “Company”), formerly AIkido Pharma, Inc., was founded in 1967 as Spherix Incorporated. Since 2017, the Company has operated as a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics and their related patent technology. In an effort to enhance shareholder value, in June of 2022, the Company formed a wholly owned financial services subsidiary, Dominari Financial Inc. (“Dominari”), with the intent of shifting the Company’s primary operating focus away from biotechnology to the fintech and financial services industries. Through Dominari, the Company acquired Dominari Securities LLC (Dominari Securities), an introducing broker-dealer, registered with the Financial Industry Regulatory Authority (“FINRA”) and an investment adviser registered with the Securities and Exchange Commission (“SEC”). Dominari Securities provides investment advisory services and annuity and insurance products of certain insurance carriers as an insurance agency through independent and affiliated brokers. Additionally, AIkido Labs, LLC (“Aikido Labs”), another wholly owned subsidiary of the Company, has historically explored opportunities in high growth industries. To date, Aikido Labs has made equity investments in Anduril Industries, Inc, Databricks, Inc., Discord, Inc., Epic Games, Inc., Payward, Inc. dba Kraken, Space Exploration Technologies Corp. dba SpaceX, Tevva Motors Ltd., Thrasio, LLC, and Yanka Industries, Inc. dba Masterclass. Finally, the Company is in the process of winding down its historical pipeline of biotechnology assets consisting of patented technologies from leading universities and researchers, including prospective treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. Reverse Stock Split On June 7, 2022, the Company effected a seventeen-for-one (17-for-1) reverse stock split of its class of common stock (the “Reverse Stock Split”). The Reverse Stock Split, which was approved by stockholders at an annual stockholder meeting on May 20, 2022, was consummated pursuant to a Certificate of Amendment filed with the Secretary of State of Delaware on June 2, 2022. The Reverse Stock Split was effective on June 7, 2022. All references to common stock, convertible preferred stock, warrants to purchase common stock, options to purchase common stock, restricted stock units, restricted stock awards, share data, per share data and related information contained in these unaudited condensed consolidated financial statements have been retrospectively adjusted to reflect the effect of the Reverse Stock Split for all periods presented. Payment for fractional shares resulting from the reverse stock split amounted to $0.03 million.

Liquidity and Capital Resources

Liquidity and Capital Resources	3 Months Ended
	Mar. 31, 2023
Liquidity and Capital Resources [Abstract]
Liquidity and Capital Resources	Note 2. Liquidity and Capital Resources The Company continues to incur ongoing administrative and other expenses, including public company expenses, in excess of corresponding (non-financing related) revenue. While the Company continues to implement its business strategy, it intends to finance its activities through managing current cash on hand from the Company’s past equity offerings. Based upon projected cash flow requirements, the Company has adequate cash to fund its operations for at least the next twelve months from the date of the issuance of these unaudited condensed consolidated financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3. Summary of Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those previously disclosed in the 2022 Annual Report other than those discussed below. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), and in conformity with the rules and regulations of the SEC. In the opinion of management, these financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the results of the interim periods presented. The condensed balance sheet at December 31, 2022, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company’s policy is to consolidate all entities that it controls by ownership of a majority of the membership interest or outstanding voting stock. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Aikido Labs, Dominari, and Dominari Securities. All significant intercompany balances and transactions have been eliminated in consolidation. Results for interim periods are not necessarily indicative of results to be expected for a full year or any future period. Use of Estimates The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions. Deposits with clearing broker Deposits with clearing broker consisted of approximately $3.4 million held in money market funds and liquid insured deposits and a $0.1 million good faith deposit maintained by the Company with its clearing broker. These amounts are recorded as deposits with clearing broker within the unaudited condensed consolidated balance sheet as of March 31, 2023. Leases The Company accounts for its leases under ASC 842, Leases Leases Recently adopted accounting standards In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers Effect of new accounting pronouncements not yet adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . In March 2023, the FASB issued ASU 2023-01, Leases Effect of new accounting pronouncements to be adopted in future periods The Company reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a significant impact on the unaudited condensed consolidated financial statements.

FPS Acquisition

FPS Acquisition	3 Months Ended
	Mar. 31, 2023
FPS Acquisition [Abstract]
FPS Acquisition	Note 4. FPS Acquisition On September 9, 2022, Dominari entered into a membership interest purchase agreement, as amended and restated on March 27, 2023 (the “FPS Purchase Agreement”) with Fieldpoint Private Bank & Trust (“Seller”), a Connecticut bank, for the purchase of its wholly owned subsidiary, Fieldpoint Private Securities, LLC, a Connecticut limited liability company (“FPS”), that is a broker-dealer registered with FINRA and an investment adviser registered with the SEC (the “FPS Acquisition”). Pursuant to the terms of the FPS Purchase Agreement, Dominari purchased from the Seller 100% of the membership interests in FPS (the “Membership Interests”). FPS’s registered broker-dealer and investment adviser businesses was renamed and will operate as Dominari Securities, a wholly owned subsidiary of Dominari. The FPS Purchase Agreement provides for Dominari’s acquisition of FPS’s Membership Interests in two closings, the first of which occurred on October 4, 2022 (the “Initial Closing”), at which Dominari paid to the Seller $2.0 million in consideration for a transfer by the Seller to Dominari of 20% of the FPS Membership Interests. Following the Initial Closing, FPS filed a continuing membership application requesting approval for a change of ownership, control, or business operations with FINRA in accordance with FINRA Rule 1017 (the “Rule 1017 Application”). The Rule 1017 Application was approved by FINRA on March 20, 2023. The second closing (the “Second Closing”) occurred on March 27, 2023. Dominari paid to the Seller an additional approximate $1.6 million consideration for a transfer by the Seller to Dominari of the remaining 80% of the Membership Interests. Consideration Transferred The FPS Acquisition was accounted for a business combination under ASC 805. Under the terms of the FPS Purchase Agreement and subsequent Amendments and Side Letters, 100% of the membership interest was acquired for cash consideration of approximately $3.4 million, which reflected the fair value of net assets acquired, plus a $1 purchase price. At March 31, 2023, Dominari had not finalized the purchase accounting related to the fair value of assets acquired in the FPS Acquisition. Pursuant to the Initial Closing and Second Closing, Dominari had wired a total of approximately $3.6 million in cash to the Seller. The purchase price allocation identified net assets of approximately $3.4 million, resulting in a receivable due from the Seller for approximately $0.2 million. The receivable is not included within the consideration transferred as part of the FPS Acquisition but is included within prepaid expenses and other assets within the unaudited condensed consolidated balance sheet as of March 31, 2023. Under the acquisition method of accounting, the assets acquired, and liabilities assumed of FPS were recorded as of the acquisition date, at their respective fair values, and consolidated with those of the Company. Acquisition-related costs are not included as a component of consideration transferred but are expensed in the periods in which costs are incurred. The Company incurred approximately $0.3 million of transaction costs associated with the FPS Acquisition. The transaction costs are included in general and administrative expenses in the unaudited condensed consolidated statement of operations. Fair Value of Net Assets Acquired The Company is in the process of finalizing the purchase price allocation as of March 31, 2023. The following table summarizes the fair values of the assets acquired and liabilities assumed of FPS at the date of acquisition: March 27, 2023 (Unaudited) ASSETS Cash and cash equivalents $ 92 Deposits with Clearing Broker-Dealer 3,550 Other receivables 53 Prepaid and other current assets 89 Total assets acquired 3,784 Liabilities Accrued expenses $ 273 Accrued commissions 25 Wealth management liabilities 62 Total liabilities assumed 360 Total net assets of FPS Acquisition 3,424 Dominari Securities reported a net loss of approximately $0.7 million for the period ended March 31, 2023. Revenue for the period ended March 31, 2023, was not material. The net loss was a result of professional service costs incurred of approximately $0.6 million, which included transaction costs of approximately $0.3 million. The approximate $0.6 million of professional service costs is included in the general and administrative expenses in the unaudited condensed consolidated statement of operations. Proforma disclosures were omitted for this acquisition as it does not have a significant impact on the Company’s financial results.

Investments in Marketable Secur

Investments in Marketable Securities	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments in Marketable Securities	Note 5. Investments in Marketable Securities The realized gain or loss, unrealized gain or loss, and dividend income related to marketable securities for the three months ended March 31, 2023 and 2022, which are recorded as a component of gains and (losses) on marketable securities on the unaudited condensed consolidated statements of operations, are as follows ($ in thousands): Three Months Ended 2023 2022 Realized (loss) gain $ (56 ) $ (224 ) Unrealized loss (130 ) (333 ) Dividend income 119 60 Total $ (65 ) $ (497 )

Short-Term Investments

Short-Term Investments	3 Months Ended
	Mar. 31, 2023
Short-Term Investments [Abstract]
Short-term investments	Note 6. Short-term investments The following table presents the Company’s short-term investments as of March 31, 2023, and December 31, 2022 ($ in thousands): March 31, December 31, Investment in Vicinity Motor Corp. 13 13 Total 13 13 There was no change in the fair value of the short-term investments for the three months ended March 31, 2023. The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: March 31, December 31, Option term (in years) 1.6 1.8 Volatility 76.90 % 76.90 % Risk-free interest rate 4.47 % 4.47 % Expected dividends 0.00 % 0.00 % Stock price $ 0.96 $ 0.96

Long-Term Investments

Long-Term Investments	3 Months Ended
	Mar. 31, 2023
Long-Term Investments [Abstract]
Long-Term Investments	Note 7. Long-Term Investments The following table presents the Company’s other investments as of March 31, 2023, and December 31, 2022 ($ in thousands): March 31, December 31, Investment in Kerna Health Inc $ 4,940 $ 4,940 Investment in Kaya Now - - Investment in Tevva Motors 2,794 2,794 Investment in ASP Isotopes - - Investment in AerocarveUS Corporation 1,000 1,000 Investment in Qxpress 1,000 1,000 Investment in Masterclass 170 170 Investment in Kraken 597 597 Investment in Epic Games 3,500 3,500 Investment in Tesspay 2,500 2,500 Investment in SpaceX 3,674 3,674 Investment in Databricks 1,200 1,200 Investment in Discord 476 476 Investment in Thrasio 300 300 Investment in Automation Anywhere 476 476 Investment in Anduril 476 476 Total $ 23,103 $ 23,103 There was no change in the value of the long-term investments for the three months ended March 31, 2023. Investment in Kerna Health Inc On September 15, 2021, the Company entered into a securities purchase agreement (the “Kerna Securities Purchase Agreement”) with Kerna Health Inc., (“Kerna”). Under the Kerna Securities Purchase Agreement, the Company agreed to purchase 1,333,334 shares of common stock of Kerna for $1.0 million. Kerna, a private company, raised capital during the fourth quarter of 2021, increasing its share price value to $2.85 per share. Therefore, the Company recorded a $2.8 million unrealized gain on this investment during the fourth quarter of 2021. The investment in Kerna was valued at $3.8 million as of December 31, 2021. In May 2022, the Company purchased additional 400,000 shares of common stock of Kerna Health Inc, (“Kerna”) for approximately $1.1 million. The investment in Kerna was valued at $4.9 million as of March 31, 2023. Investment in Kaya Holding Corp. (a.k.a Kaya Now Inc.) On September 29, 2021, the Company entered into a securities purchase agreement (the “Kaya Securities Purchase Agreement”) with Kaya Holding Corp., (“Kaya”). Under the Kaya Securities Purchase Agreement, the Company agreed to purchase 8,325,000 shares of common stock of Kaya for approximately $0.7 million. Kaya, a private company, raised capital during the fourth quarter of 2021, increasing its share price value to $0.20 per share. Therefore, the Company recorded approximately $1.0 million in unrealized gain on this investment during the fourth quarter of 2021. The investment in Kaya was valued at approximately $1.7 million as of December 31, 2021. On March 2, 2022, the Company purchased additional 3,375,000 shares of common stock of Kaya Now Inc., aka Kaya Holding Corp., (“Kaya”) for approximately $0.6 million. On July 21, 2022, in consideration for extending the maturity date of the Kaya Now Promissory Note (See Note 8 – Notes Receivable During the fourth quarter of 2022, the Company identified indicators of impairment for the Kaya investment as a result of adverse changes in Kaya’s business operations, including liquidity concerns. As a result, the Company recorded an impairment charge of approximately $3.1 million in the fourth quarter of 2022. The impairment charge represents an unrealized impairment loss of approximately $2.5 million in stock, $0.5 million related to the promissory note (see Note 8 – Notes Receivable Fair Value of Financial Assets and Liabilities Investment in Tevva Motors Ltd. On September 22, 2021, the Company entered into a securities purchase agreement (the “Tevva Motors Subscription Agreement”) with Big Sky Opportunities Fund, LLC, who handled the offering for Tevva Motors. Under the Tevva Motors Subscription Agreement, the Company agreed to purchase 29,004 interests of Tevva Motors for approximately $1.0 million. Subsequently, on September 30, 2021, the Company entered into a second securities purchase agreement with Big Sky Opportunities Fund, LLC to purchase an additional 29,004 interests of Tevva Motors for approximately $1.0 million. The investment in Tevva was valued at approximately $2.0 million as of December 31, 2021. Tevva Motors (“Tevva”), a private company, raised capital during the first quarter of 2022, increasing its share price value to $58.0 per share. Subsequent to the first quarter raise, Tevva had an additional fund raise in the second quarter at a lower valuation of $48.16 per share. Therefore, the Company recorded a first quarter of 2022 unrealized gain of approximately $1.4 million offset by a second quarter of 2022 unrealized loss of approximately $0.6 million. The investment in Tevva was valued at approximately $2.8 million as of as of March 31, 2023. Investment in ASP Isotopes Inc. On November 18, 2021, the Company entered into a securities purchase agreement (the “ASP Securities Purchase Agreement”) with ASP Isotopes Inc., (“ASP Isotopes”). Under the ASP Securities Purchase Agreement, the Company agreed to purchase 500,000 shares of common stock of ASP Isotopes for $1.0 million. The investment in ASP Isotopes was valued at approximately $1.0 million as of December 31, 2021. In August 2022, the Company purchased additional 100,000 shares of common stock of ASP Isotopes Inc. (“ASP”) for $0.3 million. In November 2022, the Company transferred all 600,000 shares of ASP Isotopes common stock, approximately $1.4 million, inclusive of a $0.1 million unrealized gain, to the marketable securities account. Investment in AerocarveUS Corporation On November 22, 2021, the Company entered into a securities purchase agreement (the “AerocarveUS Securities Purchase Agreement”) with AerocarveUS Corporation, (“AerocarveUS”). Under the AerocarveUS Securities Purchase Agreement, the Company agreed to purchase 250,000 shares of common stock of AerocarveUS for $1.0 million. The investment in AerocarveUS was valued at approximately $1.0 million as of December 31, 2021. The investment in AerocarveUS Corporation was valued at $1.0 million as of March 31, 2023. Investment in Qxpress On January 27, 2022, the Company entered into a securities purchase agreement (the “Qxpress Securities Purchase Agreement”) with Qxpress. Under the Qxpress Securities Purchase Agreement, the Company agreed to purchase 46,780 shares of common stock of Qxpress for $1.0 million. The investment in Qxpress was valued at $1.0 million as of March 31, 2023. Investment in Masterclass (a.k.a. Yanka Industries Inc.) In March of 2022, the Company entered into a securities purchase agreement (the “Masterclass Securities Purchase Agreement”) with Masterclass. Under the Masterclass Securities Purchase Agreement, the Company agreed to purchase 4,841 shares of common stock of Masterclass for approximately $0.2 million. Although there was also a private fund raise in the second quarter, the per share amount approximated the fair value of the Company’s investment in Masterclass, resulting in no unrealized gain or loss. The investment in Masterclass was valued at approximately $0.2 million as of March 31, 2023. Investment in Kraken (a.k.a. Payward, Inc.) In March of 2022, the Company entered into a securities purchase agreement (the “Kraken Securities Purchase Agreement”) with Kraken. Under the Kraken Securities Purchase Agreement, the Company agreed to purchase a total of 8,409 shares of common stock of Kraken for approximately $0.5 million. In August 2022, the Company entered into a common stock transfer agreement with a private seller to purchase 3,723 shares of Kraken for approximately $0.1 million. The investment in Kraken was valued at approximately $0.6 million as of March 31, 2023. Investment in Epic Games, Inc. On March 22, 2022, the Company entered into a securities purchase agreement (the “Epic Games Securities Purchase Agreement”) with Epic Games. Under the Epic Games Securities Purchase Agreement, the Company agreed to purchase an aggregate of 901 shares of common stock of Epic Games for a total $1.5 million. In April 2022, the Company invested an additional $2 million for the purchase of additional shares of common stock of Epic Games. Although there was also a fund raise in April, the per share amount approximated the fair value of the Company’s investment in Epic Games, resulting in no unrealized gain or loss. The investment in Epic Games was valued at $3.5 million as of March 31, 2023. Investment in Tesspay Inc. On March 23, 2022, the Company entered into a securities purchase agreement (the “Tesspay Securities Purchase Agreement”) with Tesspay. Under the Tesspay Securities Purchase Agreement, the Company agreed to purchase 1,000,000 shares of common stock of Tesspay for approximately $0.2 million. The Company also invested an additional $1.0 million for pre-IPO. Tesspay, a private company, raised capital during the first quarter of 2022, increasing its share price value to $0.25 per share. Therefore, the Company recorded $10,000 in unrealized gain on this investment during the first quarter of 2022. Subsequent to the first quarter of 2022 raise, Tesspay had an additional fund raise in the fourth quarter of 2022 at $0.50 per share, resulting in an additional unrealized gain of approximately $1.3 million. The investment in Tesspay was valued at approximately $2.5 million as of March 31, 2023. Investment in SpaceX (a.k.a. Space Exploration Technologies Corp.) On March 30, 2022, the Company entered into a securities purchase agreement (the “SpaceX Securities Purchase Agreement”) with SpaceX, under which the company agreed to purchase shares of common stock of SpaceX for $1.5 million. In April 2022, the Company invested an additional $2.0 million for the purchase of additional shares of common stock of SpaceX. The Company identified a private fund raise on January 3, 2023. Given the proximity to the December 31, 2022 valuation date, the value of the fund raise was used as a proxy for the fair valuation of the Company’s investment in SpaceX as of December 31, 2022. The per share price of SpaceX’s recent fund raise resulted in an unrealized gain of approximately $0.6 million. The investment in SpaceX was valued at approximately $3.7 million as of March 31, 2023. Investment in Databricks, Inc. On March 25, 2022, the Company entered into a securities purchase agreement (the “Databricks Securities Purchase Agreement”) with Databricks. Under the Databricks Securities Purchase Agreement, the Company agreed to purchase an aggregate of 3,830 shares of common stock of Databricks for a total $1.2 million. The investment in Databricks was valued at $1.2 million as of March 31, 2023. Investment in Discord Inc. In May 2022, the Company entered into a securities purchase agreement (the “Discord Securities Purchase Agreement”) with privately-held company Discord, Inc., a social communications platform provider that is particularly popular with gamers, as one of the Company’s pursuits of potentially high growth interests with near term monetization events. Under the Discord Securities Purchase Agreement, the Company agreed to purchase a total of 618 shares of common stock of Discord for approximately $0.5 million. The investment in Discord was valued at $0.5 million as of March 31, 2023. Investment in Thrasio Holdings, Inc. In April 2022, the Company entered into a securities purchase agreement (the “Thrasio Securities Purchase Agreement”) with privately-held company Thrasio, LLC, an aggregator of private brands of top Amazon businesses and direct-to-consumer brands, as one of the Company’s pursuits of potentially high growth interests with near term monetization events. Under the Thrasio Securities Purchase Agreement, the Company agreed to purchase a total of 20,000 shares of common stock of Thrasio for $0.3 million. The investment in Thrasio was valued at $0.3 million as of March 31, 2023. Investment in Automation Anywhere, Inc. In April 2022, the Company entered into a securities purchase agreement (the “Automation Anywhere Securities Purchase Agreement”) with privately-held company Automation Anywhere, Inc., a provider of business automation solutions, as one of the Company’s pursuits of potentially high growth interests with near term monetization events. Under the Automation Anywhere Securities Purchase Agreement, the Company agreed to purchase a total of 18,490 shares of common stock of Automation Anywhere for approximately $0.5 million. The investment in Automation Anywhere was valued at $0.5 million as of March 31, 2023. Investment in Anduril Industries, Inc. In April 2022, the Company entered into a securities purchase agreement (the “Anduril Securities Purchase Agreement”) with privately-held company Anduril Industries, Inc., a defense products company, as one of the Company’s pursuits of potentially high growth interests with near term monetization events. Under the Anduril Securities Purchase Agreement, the Company agreed to purchase a total of 14,880 shares of common stock of Anduril for approximately $0.5 million. The investment in Anduril was valued at $0.5 million as of March 31, 2023.

Notes Receivable

Notes Receivable	3 Months Ended
	Mar. 31, 2023
Notes Receivable [Abstract]
Notes Receivable	Note 8. Notes Receivable The following table presents the Company’s notes receivable as of March 31, 2023 ($ in thousands): Maturity Date Stated Interest Principal Interest Fair Value Notes receivable, at fair value Convergent convertible note, current portion 01/29/2023 8% $ 1,000 $ 277 $ 1,277 Convergent convertible note, non-current portion 01/29/2023 8% $ 750 $ - $ 750 Raefan Industries LLC Investment 6/30/2023 8% $ 4,730 $ 529 $ 5,259 American Innovative Robotics Investment 04/01/2027 8% $ 1,100 $ - $ 1,100 Notes receivable, at fair value - current portion $ 6,536 Notes receivable, at fair value - non-current portion $ 1,850 Convergent Therapeutics, Inc. Investment The Company’s 8% convertible promissory note (“Convergent Convertible Note”) issued by Convergent Therapeutics, Inc. (“Convergent”) in the principal amount of approximately $1.8 million pursuant to a Note Purchase Agreement matured on January 29, 2023. Upon maturity, Convergent entered into a contractual repayment schedule with the Company. Pursuant to the schedule, Convergent will make a total of eight payments in the amount of $250 thousand and accrued interest, every three months until fully satisfied. The principal balance of the Convergent Convertible Note is approximately $1.8 million as of March 31, 2023. The Company recorded principal repayment of $0.25 million and interest income of approximately $0.04 million on the Convergent Convertible Note as of March 31, 2023. Raefan Industries LLC Investment The Company recorded an interest income receivable of approximately $0.5 million on the Raefan Industries Promissory Note as of March 31, 2023 American Innovative Robotics, LLC Investment The Company recorded interest income of approximately $22,000 on the Robotics Promissory Note for the three months ended March 31, 2023. Kaya Now Inc. Investment During the fourth quarter of 2022, the Company identified indicators of impairment for the Kaya investment as a result of adverse changes in Kaya’s business operations, including liquidity concerns. As a result, the Company recorded an impairment charge of $0.5 million in the fourth quarter of 2022. The impairment charge represents an impairment loss of the total investment held as a promissory note resulting in a $0 balance for the Kaya Now Promissory Note as of March 31, 2023. The Company received and recorded interest income related to the Kaya Now Promissory Note of approximately $10,000 for the three months ended March 31, 2023.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	3 Months Ended
	Mar. 31, 2023
Fair Value of Financial Assets and Liabilities [Abstract]
Fair Value of Financial Assets and Liabilities	Note 9. Fair Value of Financial Assets and Liabilities Financial instruments, including cash and cash equivalents, accounts payable and accrued liabilities are carried at cost, which management believes approximates fair value due to the short-term nature of these instruments. The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The Company uses three levels of inputs that may be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or liabilities Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example, cash flow modeling inputs based on assumptions) Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. The following table presents the Company’s assets and liabilities that are measured at fair value as of March 31, 2023, and December 31, 2022 ($ in thousands): Fair value measured as of March 31, 2023 Total at Quoted Significant other Significant 2023 (Level 1) (Level 2) (Level 3) Assets Marketable securities: Equities $ 24,394 $ 24,394 $ - $ - Total marketable securities $ 24,394 $ 24,394 $ - $ - Short-term investment $ 13 $ - $ - $ 13 Notes receivable, at fair value - current portion $ 6,536 $ - $ - $ 6,536 Notes receivable, at fair value - non-current portion $ 1,850 $ - $ - $ 1,850 Fair value measured as of December 31, 2022 Total at Quoted Significant other Significant 2022 (Level 1) (Level 2) (Level 3) Assets Marketable securities: Equities $ 7,130 $ 7,130 $ - $ - Total marketable securities $ 7,130 $ 7,130 $ - $ - Short-term investment $ 13 $ - $ - $ 13 Notes receivable, at fair value - current portion $ 7,474 $ - $ - $ 7,474 Notes receivable, at fair value - non-current portion $ 1,100 $ - $ - $ 1,100 Level 3 Measurement The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets that are measured at fair value on a recurring basis ($ in thousands): Short-term investment at December 31, 2022 $ 13 Short-term investment at March 31, 2023 $ 13 Notes receivable, at fair value - current portion, at December 31, 2022 $ 7,474 Collection of principal outstanding (250 ) Accrued interest receivable, net 62 Note receivable, Convergent Convertible Note, non-current portion (750 ) Notes receivable, at fair value - current portion at March 31, 2023 $ 6,536 Notes receivable, at fair value - non-current portion, at December 31, 2022 $ 1,100 Note receivable, Convergent Convertible Note, non-current portion 750 Notes receivable, at fair value - non-current portion, value at March 31, 2023 $ 1,850 Note Receivable at fair value As of March 31, 2023, the fair value of the notes receivable was measured taking into consideration cost of the investment, market participant inputs, market conditions, liquidity, operating results and other qualitative and quantitative factors. No material change was noted in the fair value of the notes receivable during the three months ended March 31, 2023.

Leases

Leases	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Leases	Note 10. Leases On December 1, 2021, the Company entered into a Lease Agreement (the “Company’s Lease”) with Trump Tower Commercial LLC, a New York limited liability company. Under the Company’s Lease, the Company will rent a portion of the twenty-second floor at 725 Fifth Avenue, New York, New York (the “22 nd nd nd On September 23, 2022, Dominari entered into a Lease Agreement (“Dominari’s Lease”) with Trump Tower Commercial LLC, a New York limited liability company. Under Dominari’s Lease, Dominari will rent a portion of a floor at 725 Fifth Avenue, New York, New York (the “Premises”). Dominari plans to use the Premises to run its day-to-day operations. The initial term of Dominari’s Lease is seven (7) years commencing on the date that possession of the Premises is delivered to Dominari. Under Dominari’s Lease, Dominari will pay monthly rent equal to $49,368. Effective for the sixth and seventh years of Dominari’s Lease, the rent shall increase to $51,868 per month. The Company has taken possession of the Premises in February 2023. The tables below represent the Company’s lease assets and liabilities as of March 31, 2023: March 31, Assets: Operating lease right-of-use-assets $ 3,619 Liabilities: Current Operating 198 Long-term Operating 3,363 $ 3,561 The following tables summarize quantitative information about the Company’s operating leases, under the adoption of ASC 842: March 31, 2023 Weighted-average remaining lease term – operating leases (in years) 7.2 Weighted-average discount rate – operating leases 10.0 % During the three months ended March 31, 2023, the Company recorded approximately $0.1 million as lease expense to current period operations. Three Months March 31, Operating leases Operating lease cost $ 134 Operating lease expense 134 Short-term lease rent expense 30 Net rent expense $ 164 Supplemental cash flow information related to leases were as follows: Three Months March 31, Operating cash flows - operating leases $ 34 Right-of-use assets obtained in exchange for operating lease liabilities $ 2,796 As of March 31, 2023, future minimum payments during the next five years and thereafter are as follows: Operating Leases Remaining Period Ended December 31, 2023 $ 365 Year Ended December 31, 2024 750 Year Ended December 31, 2025 688 Year Ended December 31, 2026 688 Year Ended December 31, 2027 688 Year Ended December 31, 2028 770 Thereafter 1,166 Total 5,115 Less present value discount (1,554 ) Operating lease liabilities $ 3,561

Net Loss per Share

Net Loss per Share	3 Months Ended
	Mar. 31, 2023
Net Loss per Share [Abstract]
Net Loss per Share	Note 11. Net Loss per Share Basic loss per share of common stock is computed by dividing the net loss allocable to common stockholders by the weighted-average number of shares of common stock or common stock equivalents outstanding. Diluted loss per common share is computed similar to basic loss per share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share for the three months ended March 31, 2023, and 2022 are as follows: As of March 31, 2023 2022 Convertible preferred stock 34 129,446 Warrants to purchase common stock 444,796 444,796 Options to purchase common stock 31,193 28,203 Total 476,023 602,445

Stockholders_ Equity and Conver

Stockholders’ Equity and Convertible Preferred Stock	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Stockholders’ Equity and Convertible Preferred Stock	Note 12. Stockholders’ Equity and Convertible Preferred Stock Common Stock On March 6, 2023, the Company cancelled 644,499 shares of common stock as a result of retirement of 644,499 shares of treasury stock. On March 20, 2023, the Company cancelled 25,000 shares of common stock owned by a board member. Treasury Stock On January 21, 2022, the Company’s board of directors authorized a share buyback program (the “Share Buyback Program”), pursuant to which the Company authorized the Share Buyback Program in an amount of up to three million dollars. During the three months ended March 31, 2023, the Company repurchased 236,630 shares at a cost of approximately $0.9 million or $3.97 per share through marketable securities account under the Share Buyback Program. The Company records treasury stock using the cost method. On March 6, 2023, the Company retired 644,499 shares of treasury stock with original cost of approximately $3.8 million. Warrants A summary of warrant activity for the three months ended March 31, 2023, is presented below: Warrants Weighted Total Weighted Outstanding as of December 31, 2022 444,796 $ 29.25 - 3.20 Outstanding as of March 31, 2023 444,796 $ 29.25 - 2.95 Restricted Stock Awards A summary of restricted stock awards activity for the three months ended March 31, 2023, is presented below: Number of Weighted Nonvested at December 31, 2022 8,068 $ 5.64 Vested (8,068 ) 5.64 Nonvested at December 31, 2022 - $ - As of March 31, 2023, there is no unrecognized stock-based compensation expense related to restricted stock awards. Stock Options A summary of option activity under the Company’s stock option plan for the three months ended March 31, 2023 is presented below: Number of Weighted Total Intrinsic Weighted Outstanding as of December 31, 2022 31,193 $ 302.97 $ - 7.9 Outstanding as of March 31, 2023 31,193 $ 302.97 $ - 7.7 Options vested and exercisable 25,311 $ 372.00 $ - 7.4 Stock-based compensation associated with the amortization of stock option expense was approximately $4,800 and $0 for the three months ended March 31, 2023, and 2022, respectively. All stock compensation was recorded as a component of general and administrative expenses. Estimated future stock-based compensation expense relating to unvested stock options is approximately $10,000.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13. Commitments and Contingencies Legal Proceedings In the past, in the ordinary course of business, the Company actively pursued legal remedies to enforce its intellectual property rights and to stop unauthorized use of the Company’s technology. Other than ordinary routine litigation incidental to the business, the Company is not aware of any material, active or pending legal proceedings brought against it.

Regulatory

Regulatory	3 Months Ended
	Mar. 31, 2023
Regulatory [Abstract]
Regulatory	Note 14. Regulatory Dominari Securities, the Company’s broker-dealer subsidiary, is registered with the SEC as an introducing broker-dealer and is a member of FINRA. The Company’s broker-dealer subsidiary is subject to SEC Uniform Net Capital Rule (Rule 15c3-1) which requires the maintenance of minimum net capital and requires that the ratio of aggregate indebtedness to net capital, both as defined, shall not exceed 15 to 1. As such, the subsidiary is subject to the minimum net capital requirements promulgated by the SEC and has elected to calculate minimum capital requirements using the basic method permitted by Rule 15c3-1. As of March 31, 2023, Dominari Securities had net capital of approximately $2.9 million, which was approximately $2.9 million in excess of required minimum net capital of $0.1 million.

Related Party Transaction

Related Party Transaction	3 Months Ended
	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transaction	Note 15. Related Party Transaction In 2021, the Company engaged the services of Revere Securities, LLC (“Revere”) to strategically manage and build the Company’s investment processes. Kyle Wool, Board Member, is the president of Revere. The Company incurred fees of approximately $0.08 million and $0.3 million during the three months ending March 31, 2023, and 2022, respectively. These fees were included in general and administrative expense in the unaudited condensed consolidated statements of operations.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 16. Subsequent Events Soo Yu Employment Agreement On April 3, 2023, Dominari Securities, entered into an employment agreement (the Agreement), as amended on April 19, 2023, with Soo Yu. Ms. Yu is currently a member of the Company’s board of directors. Pursuant to the Agreement, which is for a term of one year, Ms. Yu will serve as a registered brokerage representative for Dominari Securities and a special projects manager for the Company. Under the Agreement, Ms. Yu is paid a base salary of $150,000 per year and receives a 60% commission on the gross revenue she generates at Dominari Securities. In addition to her base salary and commissions, Ms. Yu is eligible to receive up to $7.8 million based on the assets under management or account value of accounts she opens at Dominari Securities. Upon Ms. Yu completing all required registrations and Upon Ms. Yu Upon Ms. Yu

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2023
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), and in conformity with the rules and regulations of the SEC. In the opinion of management, these financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the results of the interim periods presented. The condensed balance sheet at December 31, 2022, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company’s policy is to consolidate all entities that it controls by ownership of a majority of the membership interest or outstanding voting stock. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Aikido Labs, Dominari, and Dominari Securities. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include stock-based compensation, the valuation of investments, the valuation of notes receivable and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.
Deposits with clearing broker	Deposits with clearing broker Deposits with clearing broker consisted of approximately $3.4 million held in money market funds and liquid insured deposits and a $0.1 million good faith deposit maintained by the Company with its clearing broker. These amounts are recorded as deposits with clearing broker within the unaudited condensed consolidated balance sheet as of March 31, 2023.
Leases	Leases The Company accounts for its leases under ASC 842, Leases Leases
Recently adopted accounting standards	Recently adopted accounting standards In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers
Effect of new accounting pronouncements not yet adopted	Effect of new accounting pronouncements not yet adopted In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions . In March 2023, the FASB issued ASU 2023-01, Leases
Effect of new accounting pronouncements to be adopted in future periods	Effect of new accounting pronouncements to be adopted in future periods The Company reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to have a significant impact on the unaudited condensed consolidated financial statements.

FPS Acquisition (Tables)

FPS Acquisition (Tables)	3 Months Ended
	Mar. 31, 2023
FPS Acquisition [Abstract]
Schedule of fair values of the assets acquired and liabilities	March 27, 2023 (Unaudited) ASSETS Cash and cash equivalents $ 92 Deposits with Clearing Broker-Dealer 3,550 Other receivables 53 Prepaid and other current assets 89 Total assets acquired 3,784 Liabilities Accrued expenses $ 273 Accrued commissions 25 Wealth management liabilities 62 Total liabilities assumed 360 Total net assets of FPS Acquisition 3,424

Investments in Marketable Sec_2

Investments in Marketable Securities (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of marketable securities	Three Months Ended 2023 2022 Realized (loss) gain $ (56 ) $ (224 ) Unrealized loss (130 ) (333 ) Dividend income 119 60 Total $ (65 ) $ (497 )

Short-Term Investments (Tables)

Short-Term Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Short-Term Investments [Abstract]
Schedule of short-term investments	March 31, December 31, Investment in Vicinity Motor Corp. 13 13 Total 13 13
Schedule of quantitative information regarding Level 3 fair value measurements inputs	March 31, December 31, Option term (in years) 1.6 1.8 Volatility 76.90 % 76.90 % Risk-free interest rate 4.47 % 4.47 % Expected dividends 0.00 % 0.00 % Stock price $ 0.96 $ 0.96

Long-Term Investments (Tables)

Long-Term Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Long-Term Investments [Abstract]
Schedule of other investments	March 31, December 31, Investment in Kerna Health Inc $ 4,940 $ 4,940 Investment in Kaya Now - - Investment in Tevva Motors 2,794 2,794 Investment in ASP Isotopes - - Investment in AerocarveUS Corporation 1,000 1,000 Investment in Qxpress 1,000 1,000 Investment in Masterclass 170 170 Investment in Kraken 597 597 Investment in Epic Games 3,500 3,500 Investment in Tesspay 2,500 2,500 Investment in SpaceX 3,674 3,674 Investment in Databricks 1,200 1,200 Investment in Discord 476 476 Investment in Thrasio 300 300 Investment in Automation Anywhere 476 476 Investment in Anduril 476 476 Total $ 23,103 $ 23,103

Notes Receivable (Tables)

Notes Receivable (Tables)	3 Months Ended
	Mar. 31, 2023
Notes Receivable [Abstract]
Schedule of notes receivable	Maturity Date Stated Interest Principal Interest Fair Value Notes receivable, at fair value Convergent convertible note, current portion 01/29/2023 8% $ 1,000 $ 277 $ 1,277 Convergent convertible note, non-current portion 01/29/2023 8% $ 750 $ - $ 750 Raefan Industries LLC Investment 6/30/2023 8% $ 4,730 $ 529 $ 5,259 American Innovative Robotics Investment 04/01/2027 8% $ 1,100 $ - $ 1,100 Notes receivable, at fair value - current portion $ 6,536 Notes receivable, at fair value - non-current portion $ 1,850

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value of Financial Assets and Liabilities [Abstract]
Schedule of fair value assets and liabilities	Fair value measured as of March 31, 2023 Total at Quoted Significant other Significant 2023 (Level 1) (Level 2) (Level 3) Assets Marketable securities: Equities $ 24,394 $ 24,394 $ - $ - Total marketable securities $ 24,394 $ 24,394 $ - $ - Short-term investment $ 13 $ - $ - $ 13 Notes receivable, at fair value - current portion $ 6,536 $ - $ - $ 6,536 Notes receivable, at fair value - non-current portion $ 1,850 $ - $ - $ 1,850 Fair value measured as of December 31, 2022 Total at Quoted Significant other Significant 2022 (Level 1) (Level 2) (Level 3) Assets Marketable securities: Equities $ 7,130 $ 7,130 $ - $ - Total marketable securities $ 7,130 $ 7,130 $ - $ - Short-term investment $ 13 $ - $ - $ 13 Notes receivable, at fair value - current portion $ 7,474 $ - $ - $ 7,474 Notes receivable, at fair value - non-current portion $ 1,100 $ - $ - $ 1,100
Schedule of fair value on a recurring basis	Short-term investment at December 31, 2022 $ 13 Short-term investment at March 31, 2023 $ 13 Notes receivable, at fair value - current portion, at December 31, 2022 $ 7,474 Collection of principal outstanding (250 ) Accrued interest receivable, net 62 Note receivable, Convergent Convertible Note, non-current portion (750 ) Notes receivable, at fair value - current portion at March 31, 2023 $ 6,536 Notes receivable, at fair value - non-current portion, at December 31, 2022 $ 1,100 Note receivable, Convergent Convertible Note, non-current portion 750 Notes receivable, at fair value - non-current portion, value at March 31, 2023 $ 1,850

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2023
Leases [Abstract]
Schedule of lease assets and liabilities	March 31, Assets: Operating lease right-of-use-assets $ 3,619 Liabilities: Current Operating 198 Long-term Operating 3,363 $ 3,561
Schedule of summarize quantitative information about the company’s operating leases	March 31, 2023 Weighted-average remaining lease term – operating leases (in years) 7.2 Weighted-average discount rate – operating leases 10.0 %
Schedule of lease expense to current period operations	Three Months March 31, Operating leases Operating lease cost $ 134 Operating lease expense 134 Short-term lease rent expense 30 Net rent expense $ 164
Schedule of supplemental cash flow information related to leases	Three Months March 31, Operating cash flows - operating leases $ 34 Right-of-use assets obtained in exchange for operating lease liabilities $ 2,796
Schedule of future minimum payments during the next five years and thereafter	Operating Leases Remaining Period Ended December 31, 2023 $ 365 Year Ended December 31, 2024 750 Year Ended December 31, 2025 688 Year Ended December 31, 2026 688 Year Ended December 31, 2027 688 Year Ended December 31, 2028 770 Thereafter 1,166 Total 5,115 Less present value discount (1,554 ) Operating lease liabilities $ 3,561

Net Loss per Share (Tables)

Net Loss per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Net Loss per Share [Abstract]
Schedule of computation of diluted loss per share	As of March 31, 2023 2022 Convertible preferred stock 34 129,446 Warrants to purchase common stock 444,796 444,796 Options to purchase common stock 31,193 28,203 Total 476,023 602,445

Stockholders_ Equity and Conv_2

Stockholders’ Equity and Convertible Preferred Stock (Tables)	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Schedule of warrant activity	Warrants Weighted Total Weighted Outstanding as of December 31, 2022 444,796 $ 29.25 - 3.20 Outstanding as of March 31, 2023 444,796 $ 29.25 - 2.95
Schedule of restricted stock awards activity	Number of Weighted Nonvested at December 31, 2022 8,068 $ 5.64 Vested (8,068 ) 5.64 Nonvested at December 31, 2022 - $ -
Schedule of stock option activity	Number of Weighted Total Intrinsic Weighted Outstanding as of December 31, 2022 31,193 $ 302.97 $ - 7.9 Outstanding as of March 31, 2023 31,193 $ 302.97 $ - 7.7 Options vested and exercisable 25,311 $ 372.00 $ - 7.4

Organization and Description _2

Organization and Description of Business and Recent Developments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Summary of Significant Accounting Policies [Abstract]
Reverse stock split	$ 30

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) $ in Millions	Mar. 31, 2023 USD ($)
Summary of Significant Accounting Policies [Abstract]
Money market funds	$ 3.4
Deposits	$ 0.1

FPS Acquisition (Details)

FPS Acquisition (Details) - USD ($)		3 Months Ended
	Oct. 04, 2022	Mar. 31, 2023	Sep. 09, 2022
FPS Acquisition (Details) [Line Items]
Cash		$ 3,400,000
Transaction costs		300,000
Net loss		700,000
Professional service costs		600,000
Professional service costs of general and administrative expenses		$ 600,000
FPS Purchase Agreement [Member]
FPS Acquisition (Details) [Line Items]
Membership interests rate	20%	80%	100%
Consideration amount	$ 2,000,000
Additional consideration		$ 1,600,000
Percentage of acquired membership interest		100%
Cash		$ 3,600,000
Purchase price		1
Net assets		3,400,000
Receivable amount		200,000
Transaction costs		$ 300,000

FPS Acquisition (Details) - Sch

FPS Acquisition (Details) - Schedule of fair values of the assets acquired and liabilities $ in Thousands	Mar. 27, 2023 USD ($)
ASSETS
Cash and cash equivalents	$ 92
Deposits with Clearing Broker-Dealer	3,550
Other receivables	53
Prepaid and other current assets	89
Total assets acquired	3,784
Liabilities
Accrued expenses	273
Accrued commissions	25
Wealth management liabilities	62
Total liabilities assumed	360
Total net assets of FPS Acquisition	$ 3,424

Investments in Marketable Sec_3

Investments in Marketable Securities (Details) - Schedule of marketable securities - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of marketable securities [Abstract]
Realized (loss) gain	$ (56)	$ (224)
Unrealized loss	(130)	(333)
Dividend income	119	60
Total	$ (65)	$ (497)

Short-Term Investments (Details

Short-Term Investments (Details) - Schedule of short-term investments - Investment in Vicinity Motor Corp. [Member] - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Short-Term Investments (Details) - Schedule of short-term investments [Line Items]
Investment in Vicinity Motor Corp.	$ 13	$ 13
Total	$ 13	$ 13

Short-Term Investments (Detai_2

Short-Term Investments (Details) - Schedule of quantitative information regarding Level 3 fair value measurements inputs - Vicinity Motor Corp [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Short-Term Investments (Details) - Schedule of quantitative information regarding Level 3 fair value measurements inputs [Line Items]
Option term (in years)	1 year 7 months 6 days	1 year 9 months 18 days
Volatility	76.90%	76.90%
Risk-free interest rate	4.47%	4.47%
Expected dividends	0%	0%
Stock price (in Dollars per share)	$ 0.96	$ 0.96

Long-Term Investments (Details)

Long-Term Investments (Details) - USD ($)							1 Months Ended											3 Months Ended		6 Months Ended	12 Months Ended
	Apr. 30, 2022	Mar. 25, 2022	Mar. 23, 2022	Mar. 22, 2022	Mar. 02, 2022	Jan. 27, 2022	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022	Apr. 30, 2022	Mar. 31, 2022	Nov. 22, 2021	Nov. 18, 2021	Sep. 30, 2021	Sep. 29, 2021	Sep. 22, 2021	Sep. 15, 2021	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022	Jul. 21, 2022	Mar. 30, 2022
Long-Term Investments (Details) [Line Items]
Purchase shares (in Shares)												250,000
Price per share (in Dollars per share)																		$ 3.97
Unrealized gain							$ 100,000
Investment																		$ 13,000			$ 13,000
Unrealized gain on investments																		(130,000)	$ (333,000)
Interest														$ 1,000,000
Lower valuation (in Dollars per share)																				$ 48.16
Shares of ASP (in Shares)							600,000
Common stock value							$ 1,400,000					$ 1,000,000
Investment value																						$ 1,000,000
Purchase of additional shares of common stock	$ 2,000,000									$ 2,000,000
Per share (in Dollars per share)																					$ 0.5
Purchase of shares																									$ 1,500,000
Investment in Kerna Health Inc [Member]
Long-Term Investments (Details) [Line Items]
Investment																	$ 1,000,000
Price per share (in Dollars per share)																						$ 2.85
Unrealized gain																						$ 2,800,000
Additional purchased shares (in Shares)									400,000
Additional shares of common stock									$ 1,100,000
Investment																		4,900,000
Investment in ASP Isotopes [Member]
Long-Term Investments (Details) [Line Items]
Investment																						3,800,000
Additional purchased shares (in Shares)								100,000
Additional shares of common stock								$ 300,000
Investment in Kaya Holding Corp [Member]
Long-Term Investments (Details) [Line Items]
Investment					$ 600,000										$ 700,000							$ 1,700,000	$ 0
Price per share (in Dollars per share)																						$ 0.2		$ 0.2
Purchase shares (in Shares)					3,375,000										8,325,000
Unrealized gain on investments																						$ 1,000,000
Issuance of shares (in Shares)																								1,000,000
Impairment charge																					$ 3,100,000
Unrealized impairment loss																					2,500,000
Related to the promissory note																					500,000
Warrants																					50,000
Investment in Tevva Motors Ltd [Member]
Long-Term Investments (Details) [Line Items]
Investment																						2,000,000
Unrealized gain																			$ 1,400,000	$ 600,000
Additional purchased shares (in Shares)														29,004
Interest																$ 29,004
Interest expense																$ 1,000,000
Investment in Tevva Motors [Member]
Long-Term Investments (Details) [Line Items]
Investment																		2,800,000
Price per share (in Dollars per share)											$ 58								$ 58
Investment in ASP Isotopes Inc [Member]
Long-Term Investments (Details) [Line Items]
Investment													$ 1,000,000									$ 1,000,000
Purchase shares (in Shares)													500,000
Investment in AerocarveUS Corporation [Member]
Long-Term Investments (Details) [Line Items]
Investment																		1,000,000
Investment in Qxpress [Member]
Long-Term Investments (Details) [Line Items]
Investment						$ 1,000,000												1,000,000
Purchase shares (in Shares)						46,780
Investment in Masterclass [Member]
Long-Term Investments (Details) [Line Items]
Investment											$ 200,000							200,000	$ 200,000
Purchase shares (in Shares)											4,841
Investment in Kraken [Member]
Long-Term Investments (Details) [Line Items]
Investment								$ 100,000			$ 500,000							600,000	500,000
Purchase shares (in Shares)								3,723			8,409
Investment in Epic Games [Member]
Long-Term Investments (Details) [Line Items]
Investment				$ 1,500,000														3,500,000
Purchase shares (in Shares)				901
Investment in Tesspay [Member]
Long-Term Investments (Details) [Line Items]
Investment			$ 200,000															2,500,000
Unrealized gain																			$ 10,000
Purchase shares (in Shares)			1,000,000
Unrealized gain on investments																					$ 1,300,000
Invested additional amount																		1,000,000
Per share price (in Dollars per share)																			$ 0.25
Investment in Anduril Industries, Inc. [Member]
Long-Term Investments (Details) [Line Items]
Investment	500,000									$ 500,000								500,000
Purchase shares (in Shares)										14,880
Unrealized gain on investments	2,000,000
Investment in Databricks [Member]
Long-Term Investments (Details) [Line Items]
Investment		$ 1,200,000																1,200,000
Purchase shares (in Shares)		3,830
Invested additional amount	600,000									$ 600,000
Investment in SpaceX [Member]
Long-Term Investments (Details) [Line Items]
Investment																		3,700,000
Discord Securities Purchase Agreement [Member]
Long-Term Investments (Details) [Line Items]
Investment									$ 500,000									500,000
Purchase shares (in Shares)									618
Thrasio Securities Purchase Agreement [Member]
Long-Term Investments (Details) [Line Items]
Investment	300,000									$ 300,000								300,000
Purchase shares (in Shares)										20,000
Investment in Automation Anywhere, Inc. [Member]
Long-Term Investments (Details) [Line Items]
Investment	$ 500,000									$ 500,000								$ 500,000
Purchase shares (in Shares)										18,490
Securities Purchase Agreement [Member]
Long-Term Investments (Details) [Line Items]
Purchase shares (in Shares)																	1,333,334

Long-Term Investments (Detail_2

Long-Term Investments (Details) - Schedule of other investments - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	$ 23,103	$ 23,103
Investment In Kerna Health Inc [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	4,940	4,940
Investment in Kaya Now [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total
Investment in Tevva Motors [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	2,794	2,794
Investment in ASP Isotopes [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total
Investment in AerocarveUS Corporation [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	1,000	1,000
Investment in Qxpress [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	1,000	1,000
Investment in Masterclass [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	170	170
Investment in Kraken [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	597	597
Investment in Epic Games [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	3,500	3,500
Investment in Tesspay [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	2,500	2,500
Investment in SpaceX [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	3,674	3,674
Investment in Databricks [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	1,200	1,200
Investment in Discord [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	476	476
Investment in Thrasio [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	300	300
Investment in Automation Anywhere [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	476	476
Investment in Anduril [Member]
Long-Term Investments (Details) - Schedule of other investments [Line Items]
Total	$ 476	$ 476

Notes Receivable (Details)

Notes Receivable (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Notes Receivable (Details) [Line Items]
Principal amount	$ 1,800,000
Accrued interest	250,000
Interest income receivable	40,000
Impairment loss	$ 0
Convergent Therapeutics, Inc. Investment [Member]
Notes Receivable (Details) [Line Items]
Convertible promissory note percentage	8%
Promissory note maturity date	Jan. 29, 2023
Principal amount	$ 1,800,000
Payment of purchase price	250,000
Raefan Industries LLC Investment [Member]
Notes Receivable (Details) [Line Items]
Interest income receivable	500,000
American Innovative Robotics, LLC Investment [Member]
Notes Receivable (Details) [Line Items]
Purchase price	22,000
Impairment charges		$ 500,000
Kaya Now Promissory Note [Member]
Notes Receivable (Details) [Line Items]
Interest income	$ 10,000

Notes Receivable (Details) - Sc

Notes Receivable (Details) - Schedule of notes receivable $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Convergent convertible note, current portion [Member]
Notes receivable, at fair value
Maturity Date	Jan. 29, 2023
Stated Interest Rate	8%
Principal Amount	$ 1,000
Interest Receivable	277
Fair Value	$ 1,277
Convergent convertible note, non-current portion [Member]
Notes receivable, at fair value
Maturity Date	Jan. 29, 2023
Stated Interest Rate	8%
Principal Amount	$ 750
Interest Receivable
Fair Value	$ 750
Raefan Industries LLC Investment [Member]
Notes receivable, at fair value
Maturity Date	Jun. 30, 2023
Stated Interest Rate	8%
Principal Amount	$ 4,730
Interest Receivable	529
Fair Value	$ 5,259
American Innovative Robotics Investment [Member]
Notes receivable, at fair value
Maturity Date	Apr. 01, 2027
Stated Interest Rate	8%
Principal Amount	$ 1,100
Interest Receivable
Fair Value	1,100
Notes receivable at fair-value - current portion [Member]
Notes receivable, at fair value
Fair Value	6,536
Notes receivable at fair-value - non-current portion [Member]
Notes receivable, at fair value
Fair Value	$ 1,850

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities (Details) - Schedule of fair value assets and liabilities - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Marketable securities:
Equities	$ 24,394	$ 7,130
Total marketable securities	24,394	7,130
Short-term investment	13	13
Notes receivable, at fair value - current portion	6,536	7,474
Notes receivable, at fair value - non-current portion	1,850	1,100
Quoted prices in active markets (Level 1) [Member]
Marketable securities:
Equities	24,394	7,130
Total marketable securities	24,394	7,130
Short-term investment
Notes receivable, at fair value - current portion
Notes receivable, at fair value - non-current portion
Significant other observable inputs (Level 2) [Member]
Marketable securities:
Equities
Total marketable securities
Short-term investment
Notes receivable, at fair value - current portion
Notes receivable, at fair value - non-current portion
Significant unobservable inputs (Level 3) [Member]
Marketable securities:
Equities
Total marketable securities
Short-term investment	13	13
Notes receivable, at fair value - current portion	6,536	7,474
Notes receivable, at fair value - non-current portion	$ 1,850	$ 1,100

Fair Value of Financial Asset_4

Fair Value of Financial Assets and Liabilities (Details) - Schedule of fair value on a recurring basis $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Schedule Of Fair Value On ARecurring Basis Abstract
Short-term investment at December 31, 2022	$ 13
Short-term investment at March 31, 2023	13
Notes receivable, at fair value - current portion, at December 31, 2022	7,474
Notes receivable, at fair value - non-current portion, at December 31, 2022	1,100
Collection of principal outstanding	(250)
Accrued interest receivable, net	62
Note receivable, Convergent Convertible Note, non-current portion	(750)
Notes receivable, at fair value - current portion at March 31, 2023	6,536
Note receivable, Convergent Convertible Note, non-current portion	750
Notes receivable, at fair value - non-current portion, value at March 31, 2023	$ 1,850

Leases (Details)

Leases (Details) - USD ($)		1 Months Ended	3 Months Ended
	Dec. 01, 2021	Sep. 23, 2022	Mar. 31, 2023	Jan. 11, 2023
Leases [Abstract]
Lease commencement date description			The initial term of the Company’s Lease is seven (7) years commencing on July 11, 2022 (“Commencement Date).
Rent payment		$ 49,368		$ 12,874
Increase rent amount	$ 13,502	$ 51,868
Lease cost			$ 100,000
Future minimum payments			5 years

Leases (Details) - Schedule of

Leases (Details) - Schedule of lease assets and liabilities $ in Thousands	Mar. 31, 2023 USD ($)
Assets:
Operating lease right-of-use-assets	$ 3,619
Current
Operating	198
Long-term
Operating	3,363
Total	$ 3,561

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of summarize quantitative information about the company’s operating leases	Mar. 31, 2023
Schedule of summarize quantitative information about the company’s operating leases [Abstract]
Weighted-average remaining lease term – operating leases (in years)	7 years 2 months 12 days
Weighted-average discount rate – operating leases	10%

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of lease expense to current period operations	3 Months Ended
	Mar. 31, 2023 USD ($)
Operating leases
Operating lease cost	$ 134
Operating lease expense	134
Short-term lease rent expense	30
Net rent expense	$ 164

Leases (Details) - Schedule o_4

Leases (Details) - Schedule of supplemental cash flow information related to leases $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Schedule of supplemental cash flow information related to leases [Abstract]
Operating cash flows - operating leases	$ 34
Right-of-use assets obtained in exchange for operating lease liabilities	$ 2,796

Leases (Details) - Schedule o_5

Leases (Details) - Schedule of future minimum payments during the next five years and thereafter $ in Thousands	Mar. 31, 2023 USD ($)
Schedule of future minimum payments during the next five years and thereafter [Member]
Remaining Period Ended December 31, 2023	$ 365
Year Ended December 31, 2024	750
Year Ended December 31, 2025	688
Year Ended December 31, 2026	688
Year Ended December 31, 2027	688
Year Ended December 31, 2028	770
Thereafter	1,166
Total	5,115
Less present value discount	(1,554)
Operating lease liabilities	$ 3,561

Net Loss per Share (Details) -

Net Loss per Share (Details) - Schedule of computation of diluted loss per share - shares	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of computation of diluted loss per share [Abstract]
Total	476,023	602,445
Convertible preferred stock [Member]
Schedule of computation of diluted loss per share [Abstract]
Total	34	129,446
Warrants to purchase common stock [Member]
Schedule of computation of diluted loss per share [Abstract]
Total	444,796	444,796
Options to purchase common stock [Member]
Schedule of computation of diluted loss per share [Abstract]
Total	31,193	28,203

Stockholders_ Equity and Conv_3

Stockholders’ Equity and Convertible Preferred Stock (Details) - USD ($)		1 Months Ended	3 Months Ended
	Mar. 06, 2023	Jan. 21, 2022	Mar. 31, 2023	Mar. 31, 2022	Mar. 20, 2023
Stockholders’ Equity and Convertible Preferred Stock (Details) [Line Items]
Shares cancelled (in Shares)	644,499				25,000
Common stock retirement shares	$ 644,499
Share Buyback Program amount		$ 3,000,000
Share repurchased (in Shares)			236,630
Amount of cost			$ 0.9
Price per share (in Dollars per share)			$ 3.97
Retired shares of treasury stock (in Shares)	644,499
Original cost	$ 3,800,000
Estimated future stock-based compensation expense			$ 10,000
Over-Allotment Option [Member]
Stockholders’ Equity and Convertible Preferred Stock (Details) [Line Items]
Stock-based compensation expense			$ 4,800	$ 0

Stockholders_ Equity and Conv_4

Stockholders’ Equity and Convertible Preferred Stock (Details) - Schedule of warrant activity - Warrant [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Outstanding beginning balance, Warrants		444,796
Outstanding beginning balance, Weighted Average Exercise Price		$ 29.25
Outstanding beginning balance, Total Intrinsic Value
Outstanding beginning balance, Weighted Average Remaining Contractual Life		3 years 2 months 12 days
Outstanding ending balance, Warrants	444,796
ending balance, Weighted Average Exercise Price	$ 29.25
ending balance, Total Intrinsic Value
ending balance, Weighted Average Remaining Contractual Life	2 years 11 months 12 days

Stockholders_ Equity and Conv_5

Stockholders’ Equity and Convertible Preferred Stock (Details) - Schedule of restricted stock awards activity	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Stockholders’ Equity and Convertible Preferred Stock (Details) - Schedule of restricted stock awards activity [Line Items]
Number of Restricted Stock Awards, beginning balance | shares	8,068
Weighted Average Grant Day Fair Value, beginning balance | $ / shares	$ 5.64
Number of Restricted Stock Awards,ending balance | shares
Weighted Average Grant Day Fair Value, ending balance | $ / shares
Number of Restricted Stock Awards, Vested | shares	(8,068)
Weighted Average Grant Day Fair Value, Vested | $ / shares	$ 5.64

Stockholders_ Equity and Conv_6

Stockholders’ Equity and Convertible Preferred Stock (Details) - Schedule of stock option activity	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Stockholders’ Equity and Convertible Preferred Stock (Details) - Schedule of stock option activity [Line Items]
Outstanding beginning balance, Number of Shares | shares	31,193
Outstanding beginning balance, Weighted Average Exercise Price | $ / shares	$ 302.97
Outstanding ending balance, Intrinsic Value | $
Outstanding beginning balance, Weighted Average Remaining Contractual Life	7 years 10 months 24 days
Outstanding ending balance, Number of Shares | shares	31,193
Outstanding ending balance, Weighted Average Exercise Price | $ / shares	$ 302.97
Outstanding ending balance, Intrinsic Value | $
Outstanding ending balance, Weighted Average Remaining Contractual Life	7 years 8 months 12 days
Number of Shares, Options vested and exercisable | shares	25,311
Weighted Average Exercise Price, Options vested and exercisable | $ / shares	$ 372
Total Intrinsic Value, Options vested and exercisable | $
Weighted Average Remaining Contractual Life (in years), Options vested and exercisable	7 years 4 months 24 days

Regulatory (Details)

Regulatory (Details) $ in Millions	Mar. 31, 2023 USD ($)
Regulatory (Details) [Line Items]
Net capital amount	$ 0.1
Excess amount	2.9
Dominari Securities [Member]
Regulatory (Details) [Line Items]
Net capital amount	$ 2.9

Related Party Transaction (Deta

Related Party Transaction (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Related Party Transactions [Abstract]
Incurred fees	$ 80	$ 300

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)		1 Months Ended
	Apr. 03, 2023	Apr. 19, 2023
Subsequent Events (Details) [Line Items]
Agreement term		1 year
Salaries	$ 7,800,000
Commission percentage	60%
Account value	$ 50,000,000
Payment fees	2,400,000
Ms. Yu [Member]
Subsequent Events (Details) [Line Items]
Salaries	150,000
Account value	150,000,000
Payment fees	2,700,000
Ms. Yu [Member] | Soo Yu Employment Agreement [Member]
Subsequent Events (Details) [Line Items]
Account value	560,000,000
Payment fees	$ 2,700,000